Stay updated on Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page footer now shows Revision: v3.3.3, and references to HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedLatest version entries in the Record History (around 2025-11-28 and 2025-12-05) include updates to the Study Status section for NCT03459846.SummaryDifference0.3%

- Check22 days agoChange DetectedRevision: v3.3.2 is now shown in the Record History, replacing the previous v3.3.1 entry.SummaryDifference0.1%

- Check29 days agoChange DetectedThe page history shows a new site revision v3.3.1 added and v3.2.0 removed. This is a minor system update that does not change core study data or trial content.SummaryDifference0.1%

- Check37 days agoChange DetectedRemoved the site-wide government funding status notice from the page, which does not affect the study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check51 days agoChange DetectedThe new screenshot shows only minor visual/UI refinements of the Record History page with no changes to listed versions or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.